Malignant B cells induce the conversion of CD4 +CD25 - T cells to regulatory T cells in B-cell non-Hodgkin lymphoma

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Han, Yixiang ^a   Wu, Jianbo ^a   Bi, Laixi ^a   Xiong, Shudao ^b   Gao, Shenmeng ^a   Yin, Lihui ^a   Jiang, Lei ^a   Chen, Chiqi ^a   Yu, Kang ^a   Zhang, Shenghui ^a,c  

^a THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; CARCINOGENESIS; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IN VITRO STUDY; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE CULTURE; LYMPHOID TISSUE; MALE; MANTLE CELL LYMPHOMA; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL MEMBRANE; CELL SEPARATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NONHODGKIN LYMPHOMA; PATHOLOGY; PHENOTYPE;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL MEMBRANE; CELL SEPARATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY;

EID: 83055164370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028649     Document Type: Article

References (41)

1. Burger JA, Ghia P, Rosenwald A, Caligaris-Cappio F, (2009) The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 114: 3367-3375.
2. Zou W, (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6: 295-307.
3. Maloy KJ, Powrie F, (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2: 816-822.
4. Piccirillo CA, Shevach EM, (2004) Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin Immunol 16: 81-88.
5. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
6. Curotto de Lafaille MA, Lafaille JJ, (2002) CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol 14: 771-778.
7. Hori S, Nomura T, Sakaguchi S, (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
8. Fontenot JD, Gavin MA, Rudensky AY, (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336.
9. Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203: 1693-1700.
10. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, et al. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203: 1701-1711.
11. Shenghui Z, Yixiang H, Jianbo W, Kang Y, Laixi B, et al. (2011) Elevated frequencies of CD4(+) CD25(+) CD127(lo) regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer 129: 1373-1381.
12. Ndhlovu LC, Loo CP, Spotts G, Nixon DF, Hecht FM, (2008) FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection. J Leukoc Biol 83: 254-262.
13. Finney OC, Riley EM, Walther M, (2010) Phenotypic analysis of human peripheral blood regulatory T cells (CD4+FOXP3+CD127lo/-) ex vivo and after in vitro restimulation with malaria antigens. Eur J Immunol 40: 47-60.
14. Ahmadzadeh M, Felipe-Silva A, Heemskerk B, Powell DJ Jr, Wunderlich JR, et al. (2008) FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions. Blood 112: 4953-4960.
15. Yuan XL, Chen L, Li MX, Dong P, Xue J, et al. (2010) Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 134: 277-288.
16. Jak M, Mous R, Remmerswaal EB, Spijker R, Jaspers A, et al. (2009) Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia. Leuk Lymphoma 50: 788-801.
17. Ju S, Qiu H, Zhou X, Zhu B, Lv X, et al. (2009) CD13+CD4+CD25hi regulatory T cells exhibit higher suppressive function and increase with tumor stage in non-small cell lung cancer patients. Cell Cycle 8: 2578-2585.
18. Mittal S, Marshall NA, Duncan L, Culligan DJ, Barker RN, et al. (2008) Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma. Blood 111: 5359-5370.
19. Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM, (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
20. Trzonkowski P, Szmit E, Mysliwska J, Dobyszuk A, Mysliwski A, (2004) CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction. Clin Immunol 112: 258-267.
21. Pang YL, Zhang HG, Peng JR, Pang XW, Yu S, et al. (2009) The immunosuppressive tumor microenvironment in hepatocellular carcinoma. Cancer Immunol Immunother 58: 877-886.
22. Liu J, Zhang N, Li Q, Zhang W, Ke F, et al. (2011) Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice. PLoS One 6: e19495.
23. Yu Y, Miller J, Leventhal JR, Tambur AR, Chandrasekaran D, et al. (2011) Requirement of Cognate CD4 T-Cell Recognition for the Regulation of Allospecific CTL by Human CD4CD127CD25FOXP3 Cells Generated in MLR. PLoS One 6: e22450.
24. Frimpong-Boateng K, van Rooijen N, Geiben-Lynn R, (2010) Regulatory T cells suppress natural killer cells during plasmid DNA vaccination in mice, blunting the CD8+ T cell immune response by the cytokine TGFbeta. PLoS One 5: e12281.
25. Xu L, Xu W, Qiu S, Xiong S, (2010) Enrichment of CCR6+Foxp3+ regulatory T cells in the tumor mass correlates with impaired CD8+ T cell function and poor prognosis of breast cancer. Clin Immunol 135: 466-475.
26. Suarez N, Alfaro C, Dubrot J, Palazon A, Bolanos E, et al. (2011) Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo. Int J Cancer 129: 374-386.
27. Takata Y, Nakamoto Y, Nakada A, Terashima T, Arihara F, et al. (2011) Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma. Cancer Lett 307: 165-173.
28. Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, et al. (2009) Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. Int J Cancer 124: 239-244.
29. Kelley TW, Pohlman B, Elson P, Hsi ED, (2007) The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol 128: 958-965.
30. Tzankov A, Meier C, Hirschmann P, Went P, Pileri SA, et al. (2008) Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica 93: 193-200.
31. Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, et al. (2006) High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108: 2957-2964.
32. Vignali DA, Collison LW, Workman CJ, (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-532.
33. Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM, (2007) CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells. Blood 110: 2537-2544.
34. Yuan XL, Chen L, Zhang TT, Ma YH, Zhou YL, et al. (2011) Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-beta1. World J Gastroenterol 17: 2019-2027.
35. Li X, Ye F, Chen H, Lu W, Wan X, et al. (2007) Human ovarian carcinoma cells generate CD4(+)CD25(+) regulatory T cells from peripheral CD4(+)CD25(-) T cells through secreting TGF-beta. Cancer Lett 253: 144-153.
36. Shevach EM, (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
37. Curran MA, Kim M, Montalvo W, Al-Shamkhani A, Allison JP, (2011) Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production. PLoS One 6: e19499.
38. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
39. Coe D, Begom S, Addey C, White M, Dyson J, et al. (2010) Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy. Cancer Immunol Immunother 59: 1367-1377.
40. Hirano F, Kaneko K, Tamura H, Dong H, Wang S, et al. (2005) Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res 65: 1089-1096.
41. Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, et al. (2009) PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 119: 551-564.